APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-surgical Body Contouring

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non-surgical Body Contouring Market Outlook and Growth Opportunities 2026

6 March 2026194 pages

Choose your research edition.

Industry ResearchNon-surgical Body Contouring Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-surgical Body Contouring Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Non-surgical Body Contouring Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-surgical Body Contouring Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-surgical Body Contouring Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Non-surgical Body Contouring market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non-surgical Body Contouring is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non-surgical Body Contouring is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non-surgical Body Contouring is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non-surgical Body Contouring market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non-surgical Body Contouring market include AbbVie, InMode, BTL Industries, Cynosure, Cutera, Lumenis, Candela Medical, Solta Medical and Alma Lasers, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Non-surgical Body Contouring market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non-surgical Body Contouring and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non-surgical Body Contouring revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Non-surgical Body Contouring market.

Non-surgical Body Contouring Segment by Company

AbbVie

InMode

BTL Industries

Cynosure

Cutera

Lumenis

Candela Medical

Solta Medical

Alma Lasers

Fotona

Bausch & Lomb

Non-surgical Body Contouring Segment by Type

Cryolipolysis

Radiofrequency

Ultrasound

Laser-based

Others

Non-surgical Body Contouring Segment by Application

Hospitals

Aesthetic Clinics

Others

Non-surgical Body Contouring Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Non-surgical Body Contouring status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Non-surgical Body Contouring key companies, revenue, market share, and recent developments.

3. To split the Non-surgical Body Contouring breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Non-surgical Body Contouring market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non-surgical Body Contouring significant trends, drivers, influence factors in global and regions.

6. To analyze Non-surgical Body Contouring competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-surgical Body Contouring market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-surgical Body Contouring and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-surgical Body Contouring.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non-surgical Body Contouring industry.

Chapter 3: Detailed analysis of Non-surgical Body Contouring company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Non-surgical Body Contouring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Non-surgical Body Contouring in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non-surgical Body Contouring Industry Trends Table 2. Non-surgical Body Contouring Industry Drivers Table 3. Non-surgical Body Contouring Industry Opportunities and Challenges Table 4. Non-surgical Body Contouring Industry Restraints Table 5. Global Non-surgical Body Contouring Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non-surgical Body Contouring Revenue Share by Company (2021-2026) Table 7. Global Non-surgical Body Contouring Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Non-surgical Body Contouring Key Company Manufacturing Base & Headquarters Table 9. Global Non-surgical Body Contouring Company, Product Type & Application Table 10. Global Non-surgical Body Contouring Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Non-surgical Body Contouring by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cryolipolysis Table 15. Significant Companies of Radiofrequency Table 16. Significant Companies of Ultrasound Table 17. Significant Companies of Laser-based Table 18. Significant Companies of Others Table 19. Global Non-surgical Body Contouring Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Non-surgical Body Contouring Sales Value by Type (2021-2026) & (US$ Million) Table 21. Global Non-surgical Body Contouring Sales Value by Type (2027-2032) & (US$ Million) Table 22. Global Non-surgical Body Contouring Sales Value Share by Type (2021-2026) Table 23. Global Non-surgical Body Contouring Sales Value Share by Type (2027-2032) Table 24. Significant Companies of Hospitals Table 25. Significant Companies of Aesthetic Clinics Table 26. Significant Companies of Others Table 27. Global Non-surgical Body Contouring Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Non-surgical Body Contouring Sales Value by Application (2021-2026) & (US$ Million) Table 29. Global Non-surgical Body Contouring Sales Value by Application (2027-2032) & (US$ Million) Table 30. Global Non-surgical Body Contouring Sales Value Share by Application (2021-2026) Table 31. Global Non-surgical Body Contouring Sales Value Share by Application (2027-2032) Table 32. Global Non-surgical Body Contouring Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Non-surgical Body Contouring Sales Value by Region (2021-2026) & (US$ Million) Table 34. Global Non-surgical Body Contouring Sales Value Share by Region (2021-2026) Table 35. Global Non-surgical Body Contouring Sales Value by Region (2027-2032) & (US$ Million) Table 36. Global Non-surgical Body Contouring Sales Value Share by Region (2027-2032) Table 37. Global Non-surgical Body Contouring Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Non-surgical Body Contouring Sales Value by Country (2021-2026) & (US$ Million) Table 39. Global Non-surgical Body Contouring Sales Value Market Share by Country (2021-2026) Table 40. Global Non-surgical Body Contouring Sales Value by Country (2027-2032) & (US$ Million) Table 41. Global Non-surgical Body Contouring Sales Value Market Share by Country (2027-2032) Table 42. AbbVie Company Information Table 43. AbbVie Business Overview Table 44. AbbVie Non-surgical Body Contouring Revenue (US$ Million) and Gross Margin (2021-2026) Table 45. AbbVie Non-surgical Body Contouring Product Portfolio Table 46. AbbVie Recent Development Table 47. InMode Company Information Table 48. InMode Business Overview Table 49. InMode Non-surgical Body Contouring Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. InMode Non-surgical Body Contouring Product Portfolio Table 51. InMode Recent Development Table 52. BTL Industries Company Information Table 53. BTL Industries Business Overview Table 54. BTL Industries Non-surgical Body Contouring Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. BTL Industries Non-surgical Body Contouring Product Portfolio Table 56. BTL Industries Recent Development Table 57. Cynosure Company Information Table 58. Cynosure Business Overview Table 59. Cynosure Non-surgical Body Contouring Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Cynosure Non-surgical Body Contouring Product Portfolio Table 61. Cynosure Recent Development Table 62. Cutera Company Information Table 63. Cutera Business Overview Table 64. Cutera Non-surgical Body Contouring Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Cutera Non-surgical Body Contouring Product Portfolio Table 66. Cutera Recent Development Table 67. Lumenis Company Information Table 68. Lumenis Business Overview Table 69. Lumenis Non-surgical Body Contouring Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Lumenis Non-surgical Body Contouring Product Portfolio Table 71. Lumenis Recent Development Table 72. Candela Medical Company Information Table 73. Candela Medical Business Overview Table 74. Candela Medical Non-surgical Body Contouring Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Candela Medical Non-surgical Body Contouring Product Portfolio Table 76. Candela Medical Recent Development Table 77. Solta Medical Company Information Table 78. Solta Medical Business Overview Table 79. Solta Medical Non-surgical Body Contouring Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Solta Medical Non-surgical Body Contouring Product Portfolio Table 81. Solta Medical Recent Development Table 82. Alma Lasers Company Information Table 83. Alma Lasers Business Overview Table 84. Alma Lasers Non-surgical Body Contouring Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Alma Lasers Non-surgical Body Contouring Product Portfolio Table 86. Alma Lasers Recent Development Table 87. Fotona Company Information Table 88. Fotona Business Overview Table 89. Fotona Non-surgical Body Contouring Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Fotona Non-surgical Body Contouring Product Portfolio Table 91. Fotona Recent Development Table 92. Bausch & Lomb Company Information Table 93. Bausch & Lomb Business Overview Table 94. Bausch & Lomb Non-surgical Body Contouring Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Bausch & Lomb Non-surgical Body Contouring Product Portfolio Table 96. Bausch & Lomb Recent Development Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. Non-surgical Body Contouring Product Image Figure 2. Global Non-surgical Body Contouring Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-surgical Body Contouring Market Size (2021-2032) & (US$ Million) Figure 4. Global Non-surgical Body Contouring Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cryolipolysis Image Figure 8. Radiofrequency Image Figure 9. Ultrasound Image Figure 10. Laser-based Image Figure 11. Others Image Figure 12. Global Non-surgical Body Contouring Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 13. Global Non-surgical Body Contouring Sales Value Share 2021 VS 2025 VS 2032 Figure 14. Global Non-surgical Body Contouring Sales Value Share by Type (2021-2032) Figure 15. Hospitals Image Figure 16. Aesthetic Clinics Image Figure 17. Others Image Figure 18. Global Non-surgical Body Contouring Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Non-surgical Body Contouring Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Non-surgical Body Contouring Sales Value Share by Application (2021-2032) Figure 21. Global Non-surgical Body Contouring Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 22. Global Non-surgical Body Contouring Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 23. North America Non-surgical Body Contouring Sales Value (2021-2032) & (US$ Million) Figure 24. North America Non-surgical Body Contouring Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Europe Non-surgical Body Contouring Sales Value (2021-2032) & (US$ Million) Figure 26. Europe Non-surgical Body Contouring Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Asia-Pacific Non-surgical Body Contouring Sales Value (2021-2032) & (US$ Million) Figure 28. Asia-Pacific Non-surgical Body Contouring Sales Value Share by Country (%), 2025 VS 2032 Figure 29. South America Non-surgical Body Contouring Sales Value (2021-2032) & (US$ Million) Figure 30. South America Non-surgical Body Contouring Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Middle East & Africa Non-surgical Body Contouring Sales Value (2021-2032) & (US$ Million) Figure 32. Middle East & Africa Non-surgical Body Contouring Sales Value Share by Country (%), 2025 VS 2032 Figure 33. USA Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. USA Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. USA Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Canada Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Canada Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Canada Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Mexico Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Mexico Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Mexico Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Germany Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Germany Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Germany Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. France Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. France Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. France Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. U.K. Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. U.K. Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. U.K. Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Italy Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Italy Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Italy Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Spain Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Spain Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Spain Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Russia Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Russia Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Russia Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Netherlands Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Netherlands Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Netherlands Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Nordic Countries Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Nordic Countries Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Nordic Countries Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. China Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. China Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. China Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Japan Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Japan Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Japan Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. South Korea Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. South Korea Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. South Korea Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. India Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. India Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. India Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Australia Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Australia Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Australia Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Southeast Asia Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Southeast Asia Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Southeast Asia Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Brazil Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Brazil Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Brazil Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Argentina Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Argentina Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Argentina Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Chile Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Chile Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Chile Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Colombia Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Colombia Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Colombia Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Peru Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Peru Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Peru Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Saudi Arabia Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Israel Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Israel Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Israel Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. UAE Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. UAE Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. UAE Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Turkey Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Turkey Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Turkey Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Iran Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Iran Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Iran Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Egypt Non-surgical Body Contouring Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Egypt Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Egypt Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Years Considered Figure 118. Research Process Figure 119. Key Executives Interviewed

Scope & coverage.

Types
  • Cryolipolysis
  • Radiofrequency
  • Ultrasound
  • Laser-based
  • Others
Applications
  • Hospitals
  • Aesthetic Clinics
  • Others
Companies covered
  • AbbVie
  • InMode
  • BTL Industries
  • Cynosure
  • Cutera
  • Lumenis
  • Candela Medical
  • Solta Medical
  • Alma Lasers
  • Fotona
  • Bausch & Lomb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Non-surgical Body Contouring Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Non-surgical Body Contouring Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Non-surgical Body Contouring Market Dynamics
  1. 2.1 Non-surgical Body Contouring Industry Trends
  2. 2.2 Non-surgical Body Contouring Industry Drivers
  3. 2.3 Non-surgical Body Contouring Industry Opportunities and Challenges
  4. 2.4 Non-surgical Body Contouring Industry Restraints
3 Non-surgical Body Contouring Market by Company
  1. 3.1 Global Non-surgical Body Contouring Company Revenue Ranking in 2025
  2. 3.2 Global Non-surgical Body Contouring Revenue by Company (2021-2026)
  3. 3.3 Global Non-surgical Body Contouring Company Ranking (2024-2026)
  4. 3.4 Global Non-surgical Body Contouring Company Manufacturing Base and Headquarters
  5. 3.5 Global Non-surgical Body Contouring Company Product Type and Application
  6. 3.6 Global Non-surgical Body Contouring Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Non-surgical Body Contouring Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Non-surgical Body Contouring Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Non-surgical Body Contouring Market by Type
  1. 4.1 Non-surgical Body Contouring Type Introduction
  2. 4.1.1 Cryolipolysis
  3. 4.1.2 Radiofrequency
  4. 4.1.3 Ultrasound
  5. 4.1.4 Laser-based
  6. 4.1.5 Others
  7. 4.2 Global Non-surgical Body Contouring Sales Value by Type
  8. 4.2.1 Global Non-surgical Body Contouring Sales Value by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Non-surgical Body Contouring Sales Value by Type (2021-2032)
  10. 4.2.3 Global Non-surgical Body Contouring Sales Value Share by Type (2021-2032)
5 Non-surgical Body Contouring Market by Application
  1. 5.1 Non-surgical Body Contouring Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Aesthetic Clinics
  4. 5.1.3 Others
  5. 5.2 Global Non-surgical Body Contouring Sales Value by Application
  6. 5.2.1 Global Non-surgical Body Contouring Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non-surgical Body Contouring Sales Value by Application (2021-2032)
  8. 5.2.3 Global Non-surgical Body Contouring Sales Value Share by Application (2021-2032)
6 Non-surgical Body Contouring Regional Value Analysis
  1. 6.1 Global Non-surgical Body Contouring Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non-surgical Body Contouring Sales Value by Region (2021-2032)
  3. 6.2.1 Global Non-surgical Body Contouring Sales Value by Region: 2021-2026
  4. 6.2.2 Global Non-surgical Body Contouring Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Non-surgical Body Contouring Sales Value (2021-2032)
  7. 6.3.2 North America Non-surgical Body Contouring Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Non-surgical Body Contouring Sales Value (2021-2032)
  10. 6.4.2 Europe Non-surgical Body Contouring Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Non-surgical Body Contouring Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Non-surgical Body Contouring Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Non-surgical Body Contouring Sales Value (2021-2032)
  16. 6.6.2 South America Non-surgical Body Contouring Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Non-surgical Body Contouring Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Non-surgical Body Contouring Sales Value Share by Country, 2025 VS 2032
7 Non-surgical Body Contouring Country-level Value Analysis
  1. 7.1 Global Non-surgical Body Contouring Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non-surgical Body Contouring Sales Value by Country (2021-2032)
  3. 7.2.1 Global Non-surgical Body Contouring Sales Value by Country (2021-2026)
  4. 7.2.2 Global Non-surgical Body Contouring Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Non-surgical Body Contouring Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Non-surgical Body Contouring Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Non-surgical Body Contouring Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AbbVie
  2. 8.1.1 AbbVie Company Information
  3. 8.1.2 AbbVie Business Overview
  4. 8.1.3 AbbVie Non-surgical Body Contouring Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AbbVie Non-surgical Body Contouring Product Portfolio
  6. 8.1.5 AbbVie Recent Developments
  7. 8.2 InMode
  8. 8.2.1 InMode Company Information
  9. 8.2.2 InMode Business Overview
  10. 8.2.3 InMode Non-surgical Body Contouring Revenue and Gross Margin (2021-2026)
  11. 8.2.4 InMode Non-surgical Body Contouring Product Portfolio
  12. 8.2.5 InMode Recent Developments
  13. 8.3 BTL Industries
  14. 8.3.1 BTL Industries Company Information
  15. 8.3.2 BTL Industries Business Overview
  16. 8.3.3 BTL Industries Non-surgical Body Contouring Revenue and Gross Margin (2021-2026)
  17. 8.3.4 BTL Industries Non-surgical Body Contouring Product Portfolio
  18. 8.3.5 BTL Industries Recent Developments
  19. 8.4 Cynosure
  20. 8.4.1 Cynosure Company Information
  21. 8.4.2 Cynosure Business Overview
  22. 8.4.3 Cynosure Non-surgical Body Contouring Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Cynosure Non-surgical Body Contouring Product Portfolio
  24. 8.4.5 Cynosure Recent Developments
  25. 8.5 Cutera
  26. 8.5.1 Cutera Company Information
  27. 8.5.2 Cutera Business Overview
  28. 8.5.3 Cutera Non-surgical Body Contouring Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Cutera Non-surgical Body Contouring Product Portfolio
  30. 8.5.5 Cutera Recent Developments
  31. 8.6 Lumenis
  32. 8.6.1 Lumenis Company Information
  33. 8.6.2 Lumenis Business Overview
  34. 8.6.3 Lumenis Non-surgical Body Contouring Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lumenis Non-surgical Body Contouring Product Portfolio
  36. 8.6.5 Lumenis Recent Developments
  37. 8.7 Candela Medical
  38. 8.7.1 Candela Medical Company Information
  39. 8.7.2 Candela Medical Business Overview
  40. 8.7.3 Candela Medical Non-surgical Body Contouring Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Candela Medical Non-surgical Body Contouring Product Portfolio
  42. 8.7.5 Candela Medical Recent Developments
  43. 8.8 Solta Medical
  44. 8.8.1 Solta Medical Company Information
  45. 8.8.2 Solta Medical Business Overview
  46. 8.8.3 Solta Medical Non-surgical Body Contouring Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Solta Medical Non-surgical Body Contouring Product Portfolio
  48. 8.8.5 Solta Medical Recent Developments
  49. 8.9 Alma Lasers
  50. 8.9.1 Alma Lasers Company Information
  51. 8.9.2 Alma Lasers Business Overview
  52. 8.9.3 Alma Lasers Non-surgical Body Contouring Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Alma Lasers Non-surgical Body Contouring Product Portfolio
  54. 8.9.5 Alma Lasers Recent Developments
  55. 8.10 Fotona
  56. 8.10.1 Fotona Company Information
  57. 8.10.2 Fotona Business Overview
  58. 8.10.3 Fotona Non-surgical Body Contouring Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Fotona Non-surgical Body Contouring Product Portfolio
  60. 8.10.5 Fotona Recent Developments
  61. 8.11 Bausch & Lomb
  62. 8.11.1 Bausch & Lomb Company Information
  63. 8.11.2 Bausch & Lomb Business Overview
  64. 8.11.3 Bausch & Lomb Non-surgical Body Contouring Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Bausch & Lomb Non-surgical Body Contouring Product Portfolio
  66. 8.11.5 Bausch & Lomb Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst